Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...
The Medford Providence Cancer Center is unveiling its new high-dose-rate (HDR) suite for patients this week for brachytherapy ...
In this episode, Barbara Schmalfeldt highlights the major updates in gynaecological cancers presented at ESMO 2025.
A new study has found that people with a learning disabilities face an increased risk of cancer overall, with particularly ...
The FDA has recently removed its “black box” warning from several estrogen-containing hormone therapy (HT) products used to treat menopause symptoms. Shannon Horning/ SciTech Editor ...
Raipur-based oncologist, Dr Jayesh Sharma, recently urged people to pay closer attention to seemingly small or everyday changes in their bodies. In an Instagram video, he listed some of the early ...
AbbVie (NYSE: ABBV) announced today that a new 6-month 45mg LUPRON DEPOT® (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment ...
Maintaining a healthy weight reduces hormonal imbalance, inflammation, and cell damage — three major risk factors for cancer.
Given the success of Research Topic <a href=" in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback